Notably, these results also emphasize and substantiate our previous findings demonstrating the substantial dedifferentiation consequences caused by loss of PRLR gene expression in these HR+ breast cancer cells encompassing increased cellular luminal-basal-mesenchymal plasticity, stemness and increased tumorigenicity [51]. The gene discussed is PRLR; the disease is breast carcinoma.